Ademen Ltd

Investor: National Institute for Health and Care Research (NIHR)

Ademen Ltd, a medical technology start-up based in the Midlands, has successfully secured £1.6 million in funding from the National Institute for Health and Care Research (NIHR). This investment is earmarked to support the trial of Ademen's innovative acoustic gut monitoring technology, designed to provide objective data on bowel activity for clinicians. Summary of transaction details: Value: £1.6 million Sector: Healthcare & Biotech Advisor: Not explicitly mentioned (support provided by University of Warwick Science Park's Ignite incubation programme) Key Entities: Ademen Ltd (Target), National Institute for Health and Care Research (NIHR) (Investor) Location: Midlands (UK) Note: This funding round represents a significant step for Ademen Ltd, allowing them to advance their technology's clinical validation and potentially revolutionize gut health diagnostics. The investment from NIHR underscores the public health potential of Ademen's device in improving patient outcomes and reducing diagnostic delays.